热门资讯> 正文
Photocure ASA报告第二季度业绩
2025-07-30 23:36
- Photocure ASA press release (OTCPK:PHCUF): Hexvix/Cysview revenues of NOK 135.6 million in the second quarter of 2025 (Q2 2024: NOK 122.4 million).
- EBITDA of NOK 14.8 million (Q2 2024: NOK 27.8 million, including a milestone payment of NOK 21.6 million) for the company.
- Photocure expects product revenue growth in the range of 7% to 11% and year-over-year EBITDA improvement in 2025.
- While the company is not providing a specific EBITDA guidance range, Photocure expects continued operating leverage flow-through in its core commercial business and significant growth in milestones this year.
More on Photocure ASA
- Historical earnings data for Photocure ASA
- Financial information for Photocure ASA
推荐文章
一周IPO丨中慧生物暗盘飙涨162%，中签一手赚超4000港元；“减肥药概念”银诺医药招股中
一周财经日历丨重磅财报周！腾讯京东季报轮番登场；美国7月CPI/PPI携手“恐怖数据”来袭
机器人投资风口来袭！世界级盛会催化下，哪些机会不容错过？
美股机会日报丨降息预期骤变！小摩称美联储年内或降息三次；SoundHound飙涨超27%
摩根大通预计美联储将在9月会议上降息25基点，接下来还会连续三次降息
英特尔首席执行官陈立武发文：关于过往职务信息有很多错误 董事会全力支持公司转型工作
美国养老金投资或迎巨变，特朗普颁令为401(k)纳入加密货币等资产铺路
外盘头条：OpenAI发布最强GPT-5；特朗普颁令允许养老金投资另类资产
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
